One Shot to Stop Group B Streptococcus
This fact sheet describes PATH’s work to develop a vaccine against Group B Streptococcus. It details current prevention methods, global disease burden, and the maternal immunization strategy. It also describes PATH’s vaccine development partnership with the Biovac Institute in Cape Town, South Africa.
» Download file (English)
191 KB PDF (Located at path.azureedge.net)
Diseases/vaccines: Group B Streptococcus (GBS)